Secondly, the degree of reduction in size achieved by primary chemotherapy may well reflect the sensitivity of micrometastases to systemic chemotherapy and thus could be a highly significant prognostic feature in patients with breast cancer.
← all excerpts
Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer.
1
—
—